|
|
|
|
| Researchers Uncover Activation Signal For Aurora-A Oncogene | Wed, 08 Sep 2010 |
| Aurora-A kinase (AurA) is an enzyme that is hyperactive in many cancers and drives tumor cell proliferation. Several AurA inhibitors are currently being tested in clinical trials to see if they slow tumor growth. Now, researchers in the Developmental Therapeutics Program at Fox Chase Cancer Center have identified an activation signal for AurA... | |
|
|
| Molecules Involved In Touch And Other Mechanically Activated Systems Identified | Mon, 06 Sep 2010 |
| Scripps Research Institute scientists have identified two proteins with potential to be important targets for research into a wide range of health problems, including pain, deafness, and cardiac and kidney dysfunction. The study was published in Science Express, the advanced, online edition of the journal Science... | |
| CyberKnife Treatment For Prostate Cancer | Sat, 04 Sep 2010 |
| CyberKnife radiosurgery treatment for prostate cancer is rapid, effective and has no side effects, with the added benefit of being non-invasive. Since 2003, the CyberKnife Center of Miami and the CyberKnife Center of Palm Beach have been providing this high tech cancer treatment longer than any facility in South Florida... | |
| New Warning Signs May Predict Kidney Transplant Failure | Fri, 03 Sep 2010 |
| Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN)... | |
|
| Some African-Americans With Chronic Kidney Disease Benefit From Lower Blood Pressure Goal | Thu, 02 Sep 2010 |
| On average, a lower blood pressure goal was no better than the standard blood pressure goal at slowing progression of kidney disease among African-Americans who had chronic kidney disease resulting from high blood pressure, according to results of the African-American Study of Kidney Disease and Hypertension (AASK), the largest and longest study of chronic kidney disease (CKD) ... | |
|
| Will Extra Protein And Exercise Help Dialysis Patients? | Thu, 02 Sep 2010 |
| University of Illinois scientists will learn whether protein supplements and cycling during treatments can help dialysis patients fight cardiovascular disease and retain physical function, thanks to a $2.1 million grant from the National Institutes of Health (NIH). "Patients with kidney failure face many health problems... | |
| Lower Blood Pressure May Preserve Kidney Function In Some Patients | Thu, 02 Sep 2010 |
| Intensively treating hypertension in some African Americans with kidney disease by pushing blood pressure well below the current recommended goal may significantly decrease the number who lose kidney function and require dialysis, suggests a Johns Hopkins-led study publishing in the New England Journal of Medicine Thursday. "This is not a panacea. We have a lot more to figure out... | |
|
|
| Potential For New Antihypertensives From Study Of System For Eliminating Salt | Wed, 01 Sep 2010 |
| A study of the body system that deals with Americans' love affair with salt may yield more insight into why so many end up hypertensive and how to better treat them. A team of scientists from the Medical College of Georgia, the University of Utah and the University of Texas at San Antonio is looking at how the kidneys know you've eaten too much salt and what they do to eliminate it... | |
| Bladder Cancer Risk May Be Decreased By Increasing Selenium Intake | Wed, 01 Sep 2010 |
| A common mineral may provide protection against bladder cancer. According to results of a study published in the September issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, selenium intake is associated with decreased risk of bladder cancer... | |
| InSightec Treats First Prostate Cancer Patients In Clinical Trials | Wed, 01 Sep 2010 |
| nSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients. Seven patients with localized low-risk prostate cancer were treated worldwide so far... | |
| Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients In Clinical Trials | Wed, 01 Sep 2010 |
| Elbit Imaging Ltd. (NASDAQ: EMITF) ("Elbit" "Company") that it's subsidiary, InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients... | |
|
| Amneal Announces FDA Approval For Spironolactone HCl Tablets | Sun, 29 Aug 2010 |
| Amneal Pharmaceuticals, LLC is pleased to announce that it has received U.S. FDA approval to manufacture Spironolactone HCl tablets in 25 mg, 50 mg and 100 mg strengths effective July 2, 2010. The Amneal generic is an AB-rated, therapeutically equivalent alternative to AldactoneŽ (a registered trademark of Pharmacia & Upjohn, Inc., a unit of Pfizer Inc.). Annual U.S... | |
| Rare Kidney Disease Caused By Genetic Copy Number Variation | Sat, 28 Aug 2010 |
| A rare form of kidney disease linked to a genetic mutation in the innate immune system has been identified by researchers funded by the Wellcome Trust and the Medical Research Council. So far, the disease, which the researchers have named CFHR5 nephropathy, has been identified in over one hundred people, all of whom are of Cypriot descent, including some living in the UK... | |
|
|
